Clinical Trial Update: Conversion to Monotherapy Study With Keppra XR for Partial Seizures [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating conversion to Keppra XR monotherapy for partial seizures in epilepsy; results from the completed study have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial-onset Seizures

Drugs mentioned

• KEPPRA XR (levetiracetam)

Snippet

Sponsor: UCB Pharma | Conditions: Epilepsy | Phase 3 | Status: COMPLETED | Results posted: 2010-12-20